PnuBioVax: Phase I data

ImmunoBiology reported data from the double-blind, U.K. Phase I SPV-001 trial in 36 healthy volunteers showing that 3 injections of 200 and 500 ug intramuscular PnuBioVax given 28 days apart significa...